Characterization of the ocular surface temperature dynamics in glaucoma subjects using long-wave infrared thermal imaging by García-Porta, Nery et al.
Characterization of the ocular surface
temperature dynamics in glaucoma subjects
using long-wave infrared thermal imaging
NERY GARCÍA-PORTA,1,* FRANCISCO JAVIER GANTES-NUÑEZ,1,2 JUAN TABERNERO,1,3 AND SHAHINA PARDHAN1
1Vision and Eye Research Institute (VERI) – School of Medicine, Anglia Ruskin University, CB1 2LZ Cambridge, UK
2Centro de Investigaciones en Óptica, C.P. 37150, León, Gto., Mexico
3Departamento de Electromagnetismo y Electrónica, Universidad de Murcia, 30100 Murcia, Spain
*Corresponding author: nery.garcia-porta@anglia.ac.uk
Received 15 November 2018; revised 18 April 2019; accepted 23 April 2019; posted 24 April 2019 (Doc. ID 352043); published 17 May 2019
We evaluated the dynamics of ocular surface temperature using thermal imaging in 21 glaucoma subjects and
19 healthy subjects. On opening of the eye, subjects with glaucoma showed significantly cooler temperatures in
the central cornea compared to the control group. The upper eyelid was also significantly cooler just before the
eye opened. Immediately after opening the eye, the dynamic of temperature change was different in the two
groups. In subjects with glaucoma, the eyes cooled significantly faster, with an average decrease of 0.49°C during
the first second compared to 0.24°C in the control group. Our results support the hypothesis that both the
stability of the tear film and changes in the ocular blood supply in subjects with glaucoma play an important
role in thermal dynamics of the ocular surface. © 2019 Optical Society of America
https://doi.org/10.1364/JOSAA.36.001015
1. INTRODUCTION
Glaucoma is an optic neuropathy characterized by the progressive
degeneration of the optic nerve. Approximately 64.3 million peo-
ple worldwide have glaucoma, and this number is predicted to
escalate to 111.8 million in 2040 due to the aging population
[1]. Glaucoma is a painless disease in general, but without treat-
ment it can lead to substantial visual field loss and blindness [2].
The pathogenesis of the disease is commonly associated with
a “vascular” theory, suggesting that glaucoma is due to an im-
paired blood supply in the eye. The optic nerve damage is
assumed to be the consequence of microvascular injuries and
low ocular perfusion pressure [the difference between intraocu-
lar pressure (IOP) and systemic blood pressure] [3,4].
Treatments for glaucoma are mostly focused on lowering
IOP based on the regular use of topical eye drops [5–7]. As
glaucoma is a progressive disease, long-term treatment is re-
quired for its control. Although there are a great variety of hy-
potensive eye drops in the market, frequent side effects affecting
the ocular surface are reported, mostly as dry eye, occurring in
up to 59% of subjects [8–10].
Dry eye disease (DED) is a multifactorial disease that
presents with tear film instability and ocular dryness symptoms
[11]. The tear film provides the cornea with nutrients, and pro-
tects and moisturizes the ocular surface. The systematic use
of glaucoma eye drops may alter the quality and functionality
of this ocular layer [8]. An unstable tear film can decrease
the quality of vision, which in turn affects daily activities like
reading or driving as well as producing symptoms of dryness
and discomfort [10,12,13].
The most commonly used method to assess tear stability is
FBUT (fluorescein tear break-up time), which requires the in-
stillation of fluorescein onto the tear film. However, the
amount of fluorescein used in the test may alter the results ob-
tained. Also, this test requires a subjective assessment of the tear
stability [14].
A non-invasive test that can give objective results is based on
long-wave infrared thermal imaging of the ocular surface. This is
a promising technology with the potential to improve the diag-
nosis and follow-up of several eye pathologies. For instance, oc-
ular thermography is able to detect inflammatory eye diseases
that typically present an elevated ocular surface temperature
(OST) [15]. Galassi et al. found lower OST in glaucoma subjects
compared to healthy subjects, and the authors suggested that this
could be related to hemodynamic alterations in the optic nerve
[16]. Other studies have also shown that the OST is lower and
the cooling rate faster in DED subjects than in healthy subjects
[17–19]. As DED is reported in subjects with glaucoma, it is
possible that the low OST reported by Galassi is due to the
eye drops. Therefore, a better understanding of the continuous
dynamical changes in the OST might help to classify the differ-
ential features of the ocular surface in glaucoma. These features
could be related to changes in the tear film dynamics, both in the
center of the cornea (where there is no vascularization) and in
peripheral vascular zones (conjunctiva and limbus areas).
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The purpose of this study is to assess the OST in different
areas of the ocular surface (vascular and avascular zones), and to
examine the continuous dynamical changes in glaucoma and
healthy subjects.
2. METHODS
The prospective study was conducted in agreement with the
tenets of the Declaration of Helsinki, and the study protocol
was reviewed and approved by the Ethics Committee of
Medical Science Faculty of Anglia Ruskin University (ARU).
Following an explanation of the nature and possible conse-
quences of the study, all participants signed a consent form
before being enrolled in the study.
To avoid fluctuations of the environmental conditions, all
tests were performed in a controlled environmental chamber
(CEC) (PSR-B, WEISS Gallenkamp) based in the Vision and
Eye Research Institute at Anglia Ruskin University. The CEC
has the capacity to maintain a set temperature between 5°C and
40°C (1°C from set value) and a relative humidity between 5%
and 85% (5% from set value). The air in the CEC circulates
constantly, with a laminar flow of 0.08 m/s. The measurements
were performed at 45% of relative humidity and 23°C. Before
doing the tests, the participants sat in the CEC for a 10 min
equilibration period so that the body could adapt to the room
temperature.
A. Subjects
The glaucoma group was recruited from the Vision and Eye
Research Institute (VERI) clinics at ARU and from the
International Glaucoma Association. The participants in the con-
trol group were recruited from VERI clinics and members of
ARU and University of Cambridge. Twenty-one glaucoma sub-
jects using glaucoma eye drops for at least six months prior to data
collection and 19 age-matched control subjects without any eye
disease were recruited. Exclusion criteria included any ocular sur-
gery in the last two years, history of corneal refractive surgery, any
acute or chronic ocular disease (except glaucoma), eye allergy, use
of any topical medications apart from glaucoma eye drops or
artificial tears, systemic diseases (e.g., diabetes) or any systemic
medications (e.g., anxiolytics) that may produce DED.
B. Thermography
Thermal videos were acquired using a long wave (17 μm) infra-
red thermal camera (Therm-App Hz, Opgal Optronic
Industries Ltd., Israel). The frame rate was 25 Hz, with a spatial
resolution of 384 × 288 pixels and high thermal sensitivity
<0.07°C. Video recordings were taken for 8 s once the sub-
jects opened their eyes after having kept them shut for around
10 s. After opening the eyes, the participants were requested to
blink normally while their head was resting on a chinrest and
they were looking at a fixed point straight ahead. Examples of
the images collected are shown in Fig. 1. The thermal images
were analyzed frame by frame using MATLAB. Three different
parameters were evaluated.
(1) The baseline temperature (T0) taken immediately after
opening the eye (t  0 s). The average temperature was calcu-
lated over two ocular surface zones, central cornea and the
periphery of the ocular surface that excluded the central cornea
(this area was manually marked with the maximum ellipse that
covered the ocular surface). In addition, the temperature of the
central superior eyelid just before the eye opened was measured.
These three zones are shown in Fig. 2. In all three cases the
diameter of the circular area (included or excluded) was 3 mm.
(2) Changes in temperature over time in the central and
peripheral ocular surface (Fig. 2). The temperatures were evalu-
ated at 0, 0.5, 1, 1.5, 4, and 8 s after opening the eye.
Fig. 1. Example of thermal images collected in an eye with glaucoma and in a healthy eye before opening the eye, and then after 1, 4, and 8 s after
opening the eye. Thermal scale runs from 29.5°C (blue tones) to 38.8°C (red tones).
Fig. 2. Areas where the temperature was evaluated.
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(3) The cooling rate in the central cornea was calculated as
the slope of the linear function at three different time intervals
after opening the eye: (i) from 0 to 2 s, (ii) from 2 to 4 s, and
(iii) from 4 to 8 s. As the participants could blink normally after
opening the eye, all the frames that corresponded to a blink after
opening the eye were manually excluded from this analysis. The
cooling rate was analyzed in an elliptical area (major axis: 5 mm;
minor axis: 3 mm) located in the center of the cornea (Fig. 2).
C. DED Clinical Tests
In addition, two commonly used clinical tests were performed:
FBUT to assess tear stability and Schirmer test to measure the
tear production.
FBUT was measured by instilling fluorescein into the lower
fornix (Bio Fluoro Fluorescein SodiumOphthalmic Strips, Biotec
Vision Care). To measure the FBUT, a slit lamp (Symphony,
Keeler Optics Ltd.) was used with a yellow filter to enhance
the contrast. One minute after instilling the fluorescein, the
participants were asked to blink a couple of times, and then
were requested to keep the eyes open for as long as possible.
The procedure was repeated three times to obtain a more re-
liable value.
Schirmer test was performed without anesthesia. A sterile
Schirmer strip (I-DEW Tearstrips, Entod Research Cell UK,
Ltd.) was placed in the temporal tarsal conjunctiva of the lower
eyelid, and the participants were requested to keep their eyes
closed for 5 min. The length of the wet strip area was measured.
D. Statistics
Statistical analysis was conducted using SPSS (SPSS Inc.,
Chicago, Illinois, USA). Shapiro–Wilk test was used to evaluate
the normal data distribution. Independent sample T test or
Mann–Whitney U test, depending on the data distribution,
were used to assess differences between both groups for T0,
FBUT, and Schirmer. Mixed ANOVA with one between-
variable (group) and one within-variable (time) was used to
evaluate the changes in cooling rate. Mixed ANOVA with one
between-variable (group) and two within-variables (time and
zone) was used to evaluate the temperature changes in the cen-
tral cornea and in the periphery of the ocular surface. When
statistically significant differences were found, Bonferroni post-
hoc correction was applied. The correlations were analyzed
using the Pearson test.
To avoid data repetition and reduce the time of the experi-
ment, data were collected only in the right eye (except if the
glaucoma participant was using hypotensive eye drops in the
left eye only, in which case the left eye was examined) of each
participant. P values lower than 0.05 were considered sta-
tistically significant.
3. RESULTS
Figure 3 shows the temperatures taken from the superior eyelid
[Fig. 3(a)] just before the eye opened, the central corneal area
[Fig. 3(b)], and the periphery of the ocular surface [Fig. 3(c)]
immediately after opening the eye. Eyes with glaucoma were
significantly cooler in the superior eyelid (P  0.046) and cen-
tral cornea (P  0.036). The difference in the peripheral ocular
surface between both groups was not significant (P  0.183).
Figure 4 shows the correlation between the temperatures in
different parts of the ocular surface. The baseline temperature
(T0) in the center of the cornea was significantly correlated
with that from the eyelid and the peripheral ocular surface
(P < 0.001), and T0 in the periphery was significantly corre-
lated with T0 in the eyelid as well (P < 0.001).
Once the eye was open, the decrease in central cornea tem-
perature was greater in glaucoma than in healthy subjects
(F  12.322, P  0.001). The average decrease was 0.49°C
in glaucoma and 0.24°C in healthy subjects during the first
second after opening the eye. A slower decrease was then ob-
served between 1 and 8 seconds [Fig. 5(a)]. This cooling behav-
ior was analyzed in more detail by calculating the cooling rate at
three different time intervals: from 0 to 2 s, 2 to 4 s, and 4 to 8 s
[Figs. 5(b), 5(c), and 5(d)]. The average cooling rate during the
Fig. 3. Values of the temperature measured in both groups, control and glaucoma, in different areas of the eye. (a) Superior eyelid just before
opening the eye; (b) center of the cornea and (c) periphery of the ocular surface just after opening the eye. Data are shown as circles and crosses for
healthy and glaucomatous eyes, respectively.
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first two seconds was −0.333 and −0.122°C∕s in the glaucoma
and control groups, respectively. For the interval between the
second and fourth seconds, it was −0.133 and −0.035°C∕s, and
for the interval between the fourth and eighth seconds the rate
was −0.115 and −0.085°C∕s in glaucoma and healthy subjects,
respectively. Statistical differences existed between these inter-
vals (F  7.549, P  0.001), with a faster cooling rate during
the first two seconds. The interaction between time interval
and group was not significant (Table 1).
Figure 6 shows the decrease of temperature in the central
cornea (panel a) and the peripheral ocular surface (panel b)
for T0 (immediately after opening the eye) and at 0.5, 1,
1.5, 4, and 8 s after opening the eye. The rate of change of
temperature was significantly greater in the glaucoma group
compared to the control group for both central and peripheral
ocular surface (F  13.978, P  0.001). On average, eight
seconds after opening the eye, the drop of temperature in
the central cornea was −1.11°C in glaucoma and −0.64°C in
healthy subjects. In the peripheral ocular surface, the drop
of temperature was −1.15°C and −0.55°C in glaucoma and con-
trol group, respectively. The temperature in the periphery was
always higher than the temperature in the center in both groups
(panels c and d).
On comparing the clinical tests for DED, although the val-
ues obtained in this study are quite low in both groups, the
glaucoma group shows significant FBUT values and nearly
significant lower Schirmer values (Table 2).
Fig. 5. (a) Average ocular surface temperature changes in the central cornea in both groups, glaucoma and control. Cooling rate (b) during the
first two seconds, (c) between seconds 2 and 4, and (d) between seconds 4 and 8 after opening the eye.
Fig. 4. Correlation between temperature in (a) the superior eyelid and center of the cornea, (b) the superior eyelid and periphery of the ocular
surface, and (c) center of the cornea and the periphery of the ocular surface.
Table 1. Results of the Repeated Measures ANOVA
Cooling Rate (°C/s) in the Central Cornea (1.5  2.5 mm)
Group (control, glaucoma) F  12.322, P  0.001
Time (0–2 s, 2–4 s, 4–8 s) F  7.549, P  0.001
Time*group F  2.529, P  0.087
Δ Temperature in two different areas: central cornea and
peripheral ocular surface
Group (control, glaucoma) F  13.978, P  0.001
Time (0 s, 0.5 s, 1 s, 1.5 s, 4 s, 8 s) F  55.715, P < 0.001
Area (center, periphery) F  12.391, P  0.001
Area*Group F  2.028, P  0.163
Time*area F  1.280, P  0.274
Group*time F  6.071, P < 0.001
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4. DISCUSSION
A. Glaucoma Eyes Are Colder than Normal Eyes
On average, the central corneas of glaucomatous eyes were
0.64°C cooler than in healthy eyes. This is in agreement with
a previous study by Galassi et al., who also found lower tem-
peratures (0.57°C) in the central cornea of the glaucomatous
eyes compared to controls [16]. In our present study, we
found that the temperature of the upper eyelid was also lower
in subjects with glaucoma. There are various reasons to explain
these data. First, it could be that glaucomatous eyes have an
impaired blood supply not only to the optic nerve but also
to the entire eye, including the vascular systems that supply
blood to the choroidal, conjunctiva, orbit, lids, and limbus
[3]. While the central cornea does not have a vascular system,
its temperature is strongly correlated to that of the eyelid as
shown in Fig. 4.
The second possible explanation could be related to the
glaucoma medication. It is well known that different hypoten-
sive drops present diverse local and systemic side effects, and
some of them affect blood pressure [7], which in turn could
influence the ocular surface temperature [20]. A decrease in
the temperature of the ocular surface may lead to a decrease
in the quality of the tear film since secretions from the glands
such as the meibonium glands are negatively affected by lower
temperatures [21]. The participants in this study used a wide
variety of glaucoma medications. The relatively small size of our
sample precluded any further analysis on effects of medication,
as different drugs may have different side effects.
The third possibility is that cooler temperatures in glaucom-
atous eyes were due to intrinsic DED in these subjects in addition
to glaucoma. Certainly, our glaucoma subjects showed more signs
of DED, as suggested by a shorter BUT and lower Schirmer val-
ues than the healthy subjects. On average, the literature shows
that subjects with DED have temperatures of around one degree
lower than healthy subjects [17]. Glaucoma subjects in our study
do show signs of DED, but whether this is caused by hypotensive
eye drops or is due to the fact that they have glaucoma cannot be
ascertained directly from the study. However, the most likely
explanation is that a combination of all these three factors (glau-
coma, side effects of the glaucoma eye drops, and DED) caused
the overall cooler temperatures in subjects with glaucoma.
B. Differences in the Ocular Surface Temperature
Dynamics of Glaucoma and Normal Eyes
Cooling rate of the central cornea was calculated at three different
temporal intervals. First, a sudden decrease of temperature oc-
curred immediately after opening the eye. Craig et al. attributed
a rapid decrease in corneal temperature to a positive latent heat of
vaporization of the tear film and consequently to a higher evapo-
ration rate [22]. This initial and rapid cooling rate was greater in
glaucoma than in healthy subjects. However, a bilinear tendency
was observed [Fig. 5(a)] in both groups, showing the rapid initial
decrease and a more attenuated cooling phase. The transition
Fig. 6. Temperature changes 0.5, 1, 4, and 8 s after opening the eye in (a) central cornea and (b) periphery of the ocular surface.
Table 2. Values of Schirmer and FBUT Tests in Glaucoma and Healthy Subjects
Control Group (mean sd) Glaucoma Group (Mean sd) Statistical Differences between Groups
FBUT (s) 6.053 2.223 4.476 2.159 t  2.274, P  0.029
Schirmer (mm) 9.176 9.382 4.737 4.805 U  101.000, P  0.052
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point between both phases occurred later (about 1 s after opening
the eye) in glaucoma subjects compared to healthy subjects,
whose initial cooling phase last only about 0.5 s on average.
During the second cooling phase, the temperature contin-
ued to drop although with a slower rate in both groups. It is
likely that the lower ambient temperature of the environment
(23°C) with respect to the temperature in the corneal surface
was responsible for this decrease in temperature [23].
Significant differences between glaucoma and control subjects
were found in the dynamic of change of central cornea temperature.
Considering that the central cornea does not have a vascular system,
after opening the eye, the changes in the temperature of the central
cornea were most likely influenced by ambient environmental tem-
perature and tear film characteristics. Since the ambient tempera-
ture was the same for all subjects (in the controlled environmental
chamber), it is likely the faster cooling rate found in glaucoma sug-
gests some instability of the tear film [24]. In fact, glaucoma group
did show shorter FBUT values. In this regard, glaucoma subjects
show similar behavior to those with DED [17–19]. Further studies
that would analyze the thermal characteristics of the ocular surface
before and after commencement of glaucoma eye drops are needed
to assess if these thermal characteristics are due to the glaucoma
itself or by the effects of topical glaucoma medication.
The analysis taken in the peripheral ocular surface area (ex-
cluding the central avascular zone) showed similar dynamics to
the central cornea (Fig. 6). Again, the drop in the temperature
here was higher in the glaucoma group than in the control group.
The faster temperature decrease found in the periphery in glau-
coma subjects suggests that this vascular zone is also affected.
The baseline temperature in the center of the cornea showed
a strong correlation with the baseline temperature of the eyelid
and the peripheral ocular surface, suggesting that central corneal
temperature is affected not only by the tear film, but also by the
ocular vascular system.
5. CONCLUSIONS
The baseline temperature is cooler in glaucomatous eyes com-
pared to healthy eyes. The cooling rate is also faster in glaucoma
than in healthy subjects. In addition, the temperature of the
peripheral area of the ocular surface which is vascular (conjunc-
tiva and limbus) tended to change more in glaucoma than in
healthy subjects (but this was not significant). In general, we
hypothesize that, although the tear film characteristics have an
important influence on the ocular surface temperature, altera-
tions in the ocular blood supply in glaucoma subjects also play
a significant role in the thermal dynamics of the ocular surface.
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